Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer

Takehiko Yokobori, Koshi Mimori, Hideshi Ishii, Masaaki Iwatsuki, Fumiaki Tanaka, Yukio Kamohara, Keisuke Ieta, Yoshiaki Kita, Yuichiro Doki, Hiroyuki Kuwano, Masaki Mori

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: Stanniocalcins are glycoprotein hormones that were originally found in the endocrine gland of bony fish. Microarray expression data from 32 paired samples of gastric cancer and normal mucosa in a public microarray database showed that the expression level of Stanniocalcin 2 was higher in gastric cancer than in normal gastric mucosa. The clinical significance of Stanniocalcin 2 expression has been observed for several cancers. However, the relationship between Stanniocalcin 2 and clinicopathological factors in gastric cancer has not yet been investigated. Materials and Methods: We examined the clinical significance of Stanniocalcin 2 in gastric cancer in 108 gastric cancer samples using real-time reverse transcription-polymerase chain reaction (RT-PCR). Immunohistochemical studies were conducted with paraffin sections. The suppression analysis of Stanniocalcin 2 using siRNA was done to determine Stanniocalcin 2's biological roles. Results: The level of Stanniocalcin 2 in cancer tissues was higher than in normal tissues (P = .0002). The high Stanniocalcin 2 expression group (n = 54) had more progressive lymph node metastasis (P = .07) and venous invasion (P = .028) than the low-expression group (n = 54). High Stanniocalcin 2 expression was an independent prognostic factor in gastric cancer patients (P = .02). Moreover, siRNA suppression of Stanniocalcin 2 in a gastric cancer cell line inhibited cellular proliferation (P < .05). Conclusions: The high expression level of Stanniocalcin 2 in gastric cancer tissues could be a very powerful marker of poor prognosis. Therefore, Stanniocalcin 2 is a promising candidate for a molecular target for the treatment of gastric cancer.

Original languageEnglish
Pages (from-to)2601-2607
Number of pages7
JournalAnnals of Surgical Oncology
Volume17
Issue number10
DOIs
Publication statusPublished - Oct 1 2010

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer'. Together they form a unique fingerprint.

  • Cite this

    Yokobori, T., Mimori, K., Ishii, H., Iwatsuki, M., Tanaka, F., Kamohara, Y., Ieta, K., Kita, Y., Doki, Y., Kuwano, H., & Mori, M. (2010). Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer. Annals of Surgical Oncology, 17(10), 2601-2607. https://doi.org/10.1245/s10434-010-1086-0